OsteoBridge™IDSF

We are very proud to announce, that the OsteoBridge System got FDA-appoval and will be available from May 2007 on.

Intramedullary Diaphyseal Segmental Defect Fixation System

For the management of segmental diaphyseal bone loss of either humerus or tibia or femur in oncology patients secondary to radical bone loss and/or resection due to tumors. The intramedullary rods can be fixed with interlocking screws without or with bone cement.

• Distal and proximal interlocking nails in different diameters and length for an easy pressfit insertion
• Guide instrument for secure finding of the interlocking holes without using the image intensifier

• Immediate weight-bearing
• Long-term stability
• Modular and versatile design
• Easy to handle
• Also suitable for cases of extensive diaphyseal graft
• Hollow, defect/resection attachment shells for antibiotic treatment or chemotherapy
• Use of bone graft material or BMP is possible